{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:21:14Z","timestamp":1771273274914,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/dss.0000000000000425","type":"journal-article","created":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T13:19:21Z","timestamp":1437830361000},"page":"898-902","source":"Crossref","is-referenced-by-count":24,"title":["Polypodium Leucotomos Supplementation in the Treatment of Scalp Actinic Keratosis"],"prefix":"10.1097","volume":"41","author":[{"given":"Matteo","family":"Auriemma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Capo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210206","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: a clinical and epidemiological revision.","volume":"87","author":"Schmitt","year":"2012","journal-title":"An Bras Dermatol"},{"key":"R2-5-20210206","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3346\/jkms.2010.25.6.924","article-title":". Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006.","volume":"25","author":"Kim","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R4-5-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1684\/ejd.2013.1923","article-title":"Therapeutic strategies for actinic keratosesa systematic review.","volume":"23","author":"Nashan","year":"2013","journal-title":"Eur J Dermatol"},{"key":"R5-5-20210206","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: treatment delivery and current indicationsactinic keratoses, Bowens disease, basal cell carcinoma.","volume":"27","author":"Morton","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-5-20210206","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2133.2007.07833.x","article-title":"Methyl aminolevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.","volume":"156","author":"Lehmann","year":"2007","journal-title":"Br J Dermatol"},{"key":"R7-5-20210206","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"; Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"R8-5-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152309787580775","article-title":". UV induced skin immunosuppression.","volume":"8","author":"Amerio","year":"2009","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"R9-5-20210206","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1562\/0031-8655(2001)073<0518:COTIIB>2.0.CO;2","article-title":"Characteristics of the immunosuppression induced by cutaneous photodynamic therapy: persistence, antigen specificity and cell type involved.","volume":"73","author":"Musser","year":"2001","journal-title":"Photochem Photobiol"},{"key":"R10-5-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1346-8138.2007.00280.x","article-title":"Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.","volume":"34","author":"Hayami","year":"2007","journal-title":"J Dermatol"},{"key":"R11-5-20210206","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/2141256a0","article-title":". Metabolic effects of calagualine, an antitumoral saponine of polypodium leucotomos.","volume":"214","author":"Horvath","year":"1967","journal-title":"Nature"},{"key":"R12-5-20210206","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2353\/ajpath.2009.090351","article-title":". Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice.","volume":"175","author":"Zattra","year":"2009","journal-title":"Am J Pathol"},{"key":"R13-5-20210206","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0781.2008.00352.x","article-title":". Polypodium leucotomos inhibits ultraviolet B radiation-induced immunosuppression.","volume":"24","author":"Siscovick","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R14-5-20210206","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaad.2004.06.027","article-title":". Oral polypodium leucotomos extract decreases ultraviolet-induced damage of human skin.","volume":"51","author":"Middelkamp-Hup","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R15-5-20210206","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2011.01413.x","article-title":". Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair.","volume":"21","author":"Kuschal","year":"2012","journal-title":"Exp Dermatol"},{"key":"R16-5-20210206","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1039\/C1PP05219E","article-title":"Unravelling UVA-induced mutagenesis.","volume":"11","author":"Sage","year":"2012","journal-title":"Photochem Photobiol Sci"},{"key":"R17-5-20210206","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet radiation and skin cancer.","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int J Dermatol"},{"key":"R18-5-20210206","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","article-title":"Guidelines for topical photodynamic therapy: update.","volume":"159","author":"Morton","year":"2008","journal-title":"Br J Dermatol"},{"key":"R19-5-20210206","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jid.2010.429","article-title":"Photodynamic therapy-induced immunosuppression in humans is prevented by reducing the rate of light delivery.","volume":"131","author":"Frost","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R20-5-20210206","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.2012.11109.x","article-title":"Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans.","volume":"167","author":"Thanos","year":"2012","journal-title":"Br J Dermatol"},{"key":"R21-5-20210206","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.3390\/ijms12128466","article-title":"Fernblock, a nutriceutical with photoprotective properties and potential preventive agent for skin photoaging and photoinduced skin cancers.","volume":"12","author":"Gonzalez","year":"2011","journal-title":"Int J Mol Sci"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000000425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:24:24Z","timestamp":1620951864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201508000-00005"}},"subtitle":["Could It Improve the Efficacy of Photodynamic Therapy?"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000425","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}